<IPO>AB&B BIO-TECH-B (02627.HK) Reportedly Oversubscribed by 4,000x, Likely Winning 3rd Place in Oversubscription This Yr
Vaccine company AB&amp;B BIO-TECH-B (02627.HK) recently extended its IPO subscription period u...
Vaccine company AB&B BIO-TECH-B (02627.HK) recently extended its IPO subscription period until yesterday (6th) noon due to extreme conditions caused by the black rainstorm warning and adverse weather.
Based on market sources, the company's public offering was oversubscribed by 4,000 times, involving over HKD210 billion, with 195,000 subscribers. It is expected to rank third in oversubscription this year, merely preceded by BLOKS (00325.HK) and MIXUE GROUP (02097.HK) .
AB&B BIO-TECH-B will announce the allotment results tomorrow (8th) and list on next Monday (11th).
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-08-06 16:25.)
Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.
